Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 29, 2023 07:00 ET | Source: Synlogic, Inc.

Synlogic Announces Pricing of $21.0 Million Underwritten Public Offering

CAMBRIDGE, Mass., Sept. 29, 2023 (GLOBE NEWSWIRE) -- Synlogic, Inc. (Nasdaq: SYBX), a clinical-stage biotechnology company advancing novel, oral, non-systemically absorbed biotherapeutics to...
September 21, 2023 07:00 ET | Source: Synlogic, Inc.

Synlogic to Participate in Chardan’s Genetic Medicines Conference

CAMBRIDGE, Mass., Sept. 21, 2023 (GLOBE NEWSWIRE) -- Synlogic, Inc. (Nasdaq: SYBX), a clinical-stage biotechnology company advancing novel, oral, non-systemically absorbed biotherapeutics to...
December 30, 2022 16:05 ET | Source: AlphaTime Acquisition Corp.

AlphaTime Acquisition Corp Announces Pricing of $60 Million Initial Public Offering

Cayman Islands, Dec. 30, 2022 (GLOBE NEWSWIRE) -- AlphaTime Acquisition Corp (the “Company”) today announced the pricing of its initial public offering of 6,000,000 units at a price of $10.00 per...
October 06, 2022 16:05 ET | Source: Dragonfly Energy Corp.

Chardan NexTech Acquisition 2 Corp. Shareholders Approve Previously Announced Business Combination with Dragonfly Energy, Corp.

RENO, Nev., Oct. 06, 2022 (GLOBE NEWSWIRE) -- Chardan NexTech Acquisition 2 Corp. (“CNTQ”) (Nasdaq: CNTQ), a publicly traded special purpose acquisition company, today announced that its...
September 27, 2022 08:30 ET | Source: Imunon, Inc.

IMUNON to Present at Chardan’s 6th Annual Genetic Medicines Conference

LAWRENCEVILLE, N.J., Sept. 27, 2022 (GLOBE NEWSWIRE) -- Imunon, Inc. (NASDAQ: IMNN), a clinical-stage drug development company, today announced that Dr. Corinne Le Goff, President and Chief...
February 24, 2022 07:00 ET | Source: Synlogic, Inc.

Synlogic To Present at Upcoming Investor and Industry Conferences

CAMBRIDGE, Mass., Feb. 24, 2022 (GLOBE NEWSWIRE) -- Synlogic, Inc. (Nasdaq: SYBX), a clinical-stage biotechnology company developing medicines for metabolic and immunological diseases through its...
September 17, 2021 12:32 ET | Source: WinVest Acquisition Corp.

WinVest Acquisition Corp. Announces Closing of $100 Million Initial Public Offering

Cambridge, MA, Sept. 17, 2021 (GLOBE NEWSWIRE) -- WinVest Acquisition Corp. (NASDAQ: WINVU, the “Company”) announced today that it closed its initial public offering of 10,000,000 units at a price...
September 28, 2020 07:00 ET | Source: Precision Biosciences

Precision BioSciences to Present at Upcoming Virtual Investor Conferences in October

DURHAM, N.C., Sept. 28, 2020 (GLOBE NEWSWIRE) -- Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage biotechnology company developing allogeneic CAR T and in vivo gene correction therapies...
April 15, 2014 08:01 ET | Source: Beamz Interactive, Inc.

Beamz Interactive, Inc. Signs Agreement With New York-Based Chardan Capital Markets

SCOTTSDALE, AZ--(Marketwired - Apr 15, 2014) - Beamz Interactive, Inc. (OTCQB: BZIC), a leading developer of state-of-the-art interactive music products, signed an agreement with Chardan Capital...
July 22, 2013 07:30 ET | Source: Worlds Inc.

Worlds Finalizes Settlement With Investor Group, Retains Chardan Capital

BOSTON, MA--(Marketwired - Jul 22, 2013) - Worlds Inc. (OTCBB: WDDD) received a majority of shareholder votes at its annual shareholder meeting on July 18th in support of Worlds' recent request to...